Henry Schein Inc

HSIC

Add to Watchlist

69.470USD

+0.120+0.17%

Close 05/13, 16:00（ET）Quotes delayed by 15 min

Henry Schein Inc's Score

Industry at a Glance

Industry Ranking

49 / 206

Overall Ranking

143 / 4490

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Henry Schein Inc Highlights

StrengthsRisks

Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.

Undervalued

The company’s latest PE is 20.79, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 124.37M shares, decreasing 16.29% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 548.00 shares of this stock.

Analyst Rating

Based on 18 analysts

Buy

Current Rating

87.261

Target Price

+23.22%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Henry Schein Inc is 6.57, ranking 137 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 3.37B, representing a year-over-year increase of 6.31%, while its net profit experienced a year-over-year increase of 2.73%.

Score

Industry at a Glance

Previous score

6.57

Change

0



Financials

3.84

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.77

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.67

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.53

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.04

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Henry Schein Inc is 6.95, ranking 136 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 20.79, which is 51.59% below the recent high of 31.51 and 12.52% above the recent low of 18.18.

Score

Industry at a Glance

Previous score

6.95

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 49/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Henry Schein Inc is 7.25, ranking 145 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 78.00, with a high of 90.00 and a low of 58.00.

Score

Industry at a Glance

Previous score

7.25

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Henry Schein Inc is 6.64, ranking 122 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 77.40 and the support level at 65.00, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.59

Change

0.05

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Henry Schein Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 109.16%, representing a quarter-over-quarter decrease of 0.90%. The largest institutional shareholder is Invesco, holding a total of 2.46M shares, representing 2.16% of shares outstanding, with 7.38% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Kohlberg Kravis Roberts & Co. L.P.

15.65M

--

Artisan Partners Limited Partnership

6.65M

-2.72%

BlackRock Institutional Trust Company, N.A.

5.33M

+1.18%

JP Morgan Asset Management

4.56M

-2.59%

State Street Investment Management (US)

4.40M

-1.77%

American Century Investment Management, Inc.

3.67M

-18.77%

Fidelity Management & Research Company LLC

3.01M

-1.29%

Dimensional Fund Advisors, L.P.

2.82M

+8.48%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Henry Schein Inc is 9.27, ranking 12 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.81. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Henry Schein Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Henry Schein Inc

HSIC

7.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.76 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.57 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.30 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment